SONOMA PHARMACEUTICALS, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
SONOMA PHARMACEUTICALS, INC. (SNOA) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $9.00 thousand for the 3-month period ending 2022-12-31, per its 10-Q filed 2024-02-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2024-02-08
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-12-31 was $9.00K.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-09-30 was $5.00K, a 66.67% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2021-09-30 was $3.00K.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2021-06-30 was $3.00K, a 83.33% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2021 was $39.00K, a 2.63% increase from fiscal 2020.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2020 was $38.00K, a 67.52% decline from fiscal 2019.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2019 was $117.00K, a 90.08% decline from fiscal 2018.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2018 was $1.18M, a 290.40% increase from fiscal 2017.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2022-12-31 | $9.00K 10-Q · filed 2024-02-08 | $14.00K derived: sum of 2 quarters · filed 2024-02-08 | |
| 2022-09-30 | $5.00K 10-Q · filed 2024-02-08 | ||
| 2021-09-30 | $3.00K 10-Q · filed 2023-02-14 | $6.00K derived: sum of 2 quarters · filed 2023-02-14 | |
| 2021-06-30 | $3.00K 10-Q · filed 2023-02-14 | ||
| 2021-03-31 | $39.00K 10-K · filed 2022-07-13 | ||
| 2020-06-30 | $18.00K 10-Q · filed 2020-11-20 | ||
| 2020-03-31 | $38.00K 10-K · filed 2021-07-14 | ||
| 2019-09-30 | $9.00K 10-Q · filed 2020-11-20 | $29.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $20.00K 10-Q · filed 2020-11-20 | ||
| 2019-03-31 | $117.00K 10-K · filed 2020-07-10 | ||
| 2018-09-30 | $16.00K 10-Q · filed 2019-11-14 | $61.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $45.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $1.18M 10-K · filed 2019-07-01 | ||
| 2017-03-31 | $302.00K 10-K · filed 2018-06-26 | ||
| 2016-03-31 | $64.00K 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |